Northsight Capital plans to acquire Stargreen Holdings to expand its business and presence in the cannabis industry.
Based on the purchase consideration, Northsight expects the acquisition to cost between $5m and $20m.
Go deeper with GlobalData
The company will issue 210 million of its common stock shares to raise funds for the acquisition.
GL Capital Management and ABG Management plan to acquire SciClone Pharma for a purchase consideration of $570m.
The companies plan to fund the acquisition through debt and equity financing.
See Also:
Morgan Stanley is acting as transaction adviser, and Skadden Arps, Slate Meagher &Flom and Fangda Law Firm are acting as legal advisers for the acquisition.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataTonghua Golden Horse Pharmaceutical Industry plans to acquire medicinal materials firm Lhasa.
The company expects the acquisition to cost up to $1.6m.
